(Q58448029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Fiona Gribble

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jens Juul Holst

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Olivia Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Emma-Leigh Synnott

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Naomi Piyaratna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ashley Douglas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Donald J Chisholm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jerry R Greenfield

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

18 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1233-1238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

21 January 2018

Glucagon-like Peptide-2.

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

The safety of oral use of L-glutamine in middle-aged and elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Oral glutamine in paediatric oncology patients: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Multiple Comparisons among Means

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Molecular mechanisms underlying nutrient-stimulated incretin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Amino acid and glucose metabolism in the postabsorptive state and following amino acid ingestion in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Protein content of the diabetic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.139824

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21593352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21593352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21593352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3945/JN.111.139824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593352%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference